U.S. Department of Health and Human Services

Topics of Interest to NIDDK

Examples of research that would be considered responsive to this announcement are listed below for illustrative purposes and are not exclusive of other appropriate activities. 

  • Completion of studies as required by the FDA for IND or Radioactive Drug Research Committee (RDRC) application
  • Assessment of devices with regard to performance standards related to the FDA approval process
  • Clinical and toxicology studies in support of an Investigational New Drug Application to the FDA 
  • Clinical studies in support of Pre-Market Approval for biomarkers/medical devices by the FDA. 
Select a category below to learn more about topics of interest:
​​​​​​